Physician profile
Philip George
NPI 1457339442
$3,709.20
in general payments reported to CMS, 2019-2025
14 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $35.75 · 2021: $299 · 2022: $2,655 · 2023: $559 · 2024: $20.81 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,061.88 | 2021-2024 | Gallant, Perclose Prostyle |
| Boston Scientific Corporation | $778.97 | 2019-2023 | |
| Medtronic, INC. | $495.89 | 2022-2023 | Micra, Selectsecure, Reveal Linq |
| Janssen Biotech, INC. | $99.72 | 2021 | |
| Janssen Pharmaceuticals, INC | $48.37 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $43.07 | 2021-2022 | |
| Glaxosmithkline, LLC. | $38.02 | 2021-2022 | |
| Pfizer INC. | $36.80 | 2020-2021 | |
| Novo Nordisk INC | $21.71 | 2021 | |
| Exact Sciences Corporation | $20.00 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $18.98 | 2020 | |
| Seqirus USA INC | $16.87 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.24 | 2021 | |
| Scynexis, INC. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.